Figure 3 represents the dysregulation of various types of lncRNAs which have a remarkable role in negatively modulating IGF1, IGF2, IGFBP2, and IGF-1R through the IGF signaling pathway in different human cancers. Table 3 summarizes the information about the role of IGF-associated lncRNAs in non-neoplastic conditions. This evidence concerns the gene IGF1R and cancer.